The development of AKI in sepsis patients was strongly associated with RDW, APACHE II score, and the biomarkers PCT, IL-6, CRP, and cystatin C. After the intervention, the incidence of AKI and AKI grade 3 significantly decreased, along with lower rates of renal replacement therapy and mortality. The gene discussed is IL6; the disease is Sepsis.